药物对比
Saxagliptin vs Nateglinide
比较saxagliptin（Onglyza，DPP-4抑制剂）与nateglinide治疗2型糖尿病：作用机制、剂量、低血糖风险、疗效及哪种可能更适合您。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when choosing between a DPP-4 inhibitor and a meglitinide for oral type 2 diabetes management.
结论
Saxagliptin is often preferred for convenience and safety profile, but nateglinide may better address postprandial hyperglycemia in selected patients.
全部药物对比